Dr Oluwasegun Afolaranmi is a Gates Cambridge Scholar and a PhD student at the Cancer Research UK Cambridge Institute, where he is investigating how to enhance immune cells to deliver what he calls the ‘kiss of death’ to cancer.
But his journey to the forefront of cancer immunology began far from the laboratories of Cambridge, in the bustling city of Lagos, Nigeria.
Growing up as the youngest member of a large, extended family, with parents who were petty traders, Segun, as he is known, was the first in his family to attend university. His academic brilliance was evident early on; he finished as the best graduating student in his high school, securing top grades across the board.
This trajectory continued at the University of Ibadan, where he completed medical school in 2019 as the best graduating student out of a cohort of 110, amassing over 30 academic and leadership awards along the way.
It was during his time as a medical student in Nigeria that Dr Afolaranmi’s career path was profoundly shaped. He was deeply moved by the experiences of cancer patients and the very limited treatment options available to them.
Attending the first World Healthcare Students’ Symposium in Africa in 2017, he learned of the disproportionately high rates of death from treatable cancers across the continent, a reality that ignited a personal passion.
“If I get very well trained in medical school and beyond, I could contribute to meaningful work, and by extension contribute to reducing the inequities in mortalities from cancer globally,” he reflects.
Driven by this conviction, Dr Afolaranmi has become a catalyst for change, not just in the lab, but on the ground. In 2018, he co-organised a pan-African conference with the Federation of African Medical Students’ Association, bringing together 600 students and 30 speakers to discuss sustainable solutions for the continent’s healthcare challenges.
He is also the co-founder of The Ganglion Initiative, a youth-focused organisation that has provided career guidance, mentorship, and scholarship opportunities to over 8,000 students across Nigeria.
His exceptional promise has been recognised with prestigious scholarships, including the Oxford Clarendon Scholarship for his MSc in Integrated Immunology at the University of Oxford, followed by the Gates Cambridge Scholarship for his current doctoral studies.
His research at Cambridge focuses on understanding the intricate workings of the immune system to develop better therapies for cancer, a disease that disproportionately impacts populations in Africa.
Ultimately, Dr Afolaranmi’s ambition is to bridge the gap between cutting-edge science and compassionate patient care. He aims to lead efforts that expand access to transformative cancer therapies in Africa, working to alleviate the unacceptable disparities that first inspired his journey.
His story is a powerful testament to how one individual’s talent and drive, rooted in a deep sense of purpose, can work to reshape the future of global health.
